| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ANIP over the last quarter tilts toward selling: insiders offloaded a net 30,412 shares worth roughly $2.2M. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
On the other side, 3 insiders reduced their position over the period. ANIP sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 333.7K | $23.99M | -5,400 | |
| CFO | 169.0K | $12.34M | -2,850 | |
| COO | 101.1K | $7.80M | - | |
| Other | 91.3K | $6.54M | - | |
| VP | 75.5K | $5.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Rowland Thomas Andrew | SVP, Head - Established Brands | Sell | 459 | $79.21 | $36,357.39 | -1.2% | -4.7% | - | |
| May 11, 2026 | Lalwani Nikhil66 | President &CEO | Sell | 55,000 | $77.57 | $4,266,350.00 | -13.6% | -3.7% | - | |
| Apr 13, 2026 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $77.95 | $38,975.00 | -0.6% | +3.5% | - | |
| Mar 13, 2026 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $72.62 | $36,310.00 | -0.6% | +15.8% | - | |
| Mar 13, 2026 | Mutz Christopher | Head Of Rare Disease | Sell | 3,162 | $71.64 | $226,525.68 | -3.3% | +15.8% | - | |
| Mar 11, 2026 | Rowland Thomas Andrew | SVP, Head - Established Brands | Sell | 4,772 | $74.91 | $357,470.52 | -11.0% | +6.4% | - | |
| Mar 9, 2026 | Mutz Christopher | Head Of Rare Disease | Sell | 5,723 | $74.19 | $424,616.98 | -5.7% | +7.1% | - | |
| Mar 9, 2026 | Davis Krista45 | SVP, Chief Hr Officer | Sell | 6,572 | $74.33 | $488,474.31 | -11.2% | +7.1% | - | |
| Mar 5, 2026 | Carey Stephen P.55 | SVP &CFO | Sale+OE | 7,312 | $75.50 | $552,031.04 | -3.8% | -0.5% | - | |
| Mar 3, 2026 | Walsh Patrick D52 | Director | Sell | 6,000 | $74.23 | $445,380.00 | -10.3% | +0.8% | - |